Toxin-triggered Liposomes for the Controlled Release of Antibiotics to Treat Infections Associated with the Gram-negative Bacterium, Aggregatibacter Actinomycetemcomitans

Overview

Journal Colloids Surf B Biointerfaces

Publisher Elsevier

Specialty Chemistry

Date 2024 Mar 31

PMID 38555763

Authors

Ziang Li

Rani Baidoun

Angela C Brown

Affiliations

Soon will be listed here.

Abstract

Antibiotic resistance has become an urgent threat to health care in recent years. The use of drug delivery systems provides advantages over conventional administration of antibiotics and can slow the development of antibiotic resistance. In the current study, we developed a toxin-triggered liposomal antibiotic delivery system, in which the drug release is enabled by the leukotoxin (LtxA) produced by the Gram-negative pathogen, Aggregatibacter actinomycetemcomitans. LtxA has previously been shown to mediate membrane disruption by promoting a lipid phase change in nonlamellar lipids, such as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-methyl (N-methyl-DOPE). In addition, LtxA has been observed to bind strongly and nearly irreversibly to membranes containing large amounts of cholesterol. Here, we designed a liposomal delivery system composed of N-methyl-DOPE and cholesterol to take advantage of these interactions. Specifically, we hypothesized that liposomes composed of N-methyl-DOPE and cholesterol, encapsulating antibiotics, would be sensitive to LtxA, enabling controlled antibiotic release. We observed that liposomes composed of N-methyl-DOPE were sensitive to the presence of low concentrations of LtxA, and cholesterol increased the extent and kinetics of content release. The liposomes were stable under various storage conditions for at least 7 days. Finally, we showed that antibiotic release occurs selectively in the presence of an LtxA-producing strain of A. actinomycetemcomitans but not in the presence of a non-LtxA-expressing strain. Together, these results demonstrate that the designed liposomal vehicle enables toxin-triggered delivery of antibiotics to LtxA-producing strains of A. actinomycetemcomitans.

References

Rams T, Degener J, van Winkelhoff A . Antibiotic resistance in human chronic periodontitis microbiota. J Periodontol. 2013; 85(1):160-9. DOI: 10.1902/jop.2013.130142. View

Osickova A, Balashova N, Masin J, Sulc M, Roderova J, Wald T . Cytotoxic activity of Kingella kingae RtxA toxin depends on post-translational acylation of lysine residues and cholesterol binding. Emerg Microbes Infect. 2018; 7(1):178. PMC: 6221878. DOI: 10.1038/s41426-018-0179-x. View

Mombelli A, Schmid B, Rutar A, Lang N . Persistence patterns of Porphyromonas gingivalis, Prevotella intermedia/nigrescens, and Actinobacillus actinomyetemcomitans after mechanical therapy of periodontal disease. J Periodontol. 2000; 71(1):14-21. DOI: 10.1902/jop.2000.71.1.14. View

Lally E, Kieba I, Sato A, Green C, Rosenbloom J, Korostoff J . RTX toxins recognize a beta2 integrin on the surface of human target cells. J Biol Chem. 1997; 272(48):30463-9. DOI: 10.1074/jbc.272.48.30463. View

Christersson L, Slots J, Rosling B, Genco R . Microbiological and clinical effects of surgical treatment of localized juvenile periodontitis. J Clin Periodontol. 1985; 12(6):465-76. DOI: 10.1111/j.1600-051x.1985.tb01382.x. View

Silver L . Challenges of antibacterial discovery. Clin Microbiol Rev. 2011; 24(1):71-109. PMC: 3021209. DOI: 10.1128/CMR.00030-10. View

Walker C . Selected antimicrobial agents: mechanisms of action, side effects and drug interactions. Periodontol 2000. 1996; 10:12-28. DOI: 10.1111/j.1600-0757.1996.tb00066.x. View

van der Koog L, Gandek T, Nagelkerke A . Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization. Adv Healthc Mater. 2021; 11(5):e2100639. PMC: 11468589. DOI: 10.1002/adhm.202100639. View

Fong K, Pacheco C, Otis L, Baranwal S, Kieba I, Harrison G . Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity. Cell Microbiol. 2006; 8(11):1753-67. PMC: 3404838. DOI: 10.1111/j.1462-5822.2006.00746.x. View

10.

Ferreira M, Ogren M, Dias J, Silva M, Gil S, Tavares L . Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance. Molecules. 2021; 26(7). PMC: 8038399. DOI: 10.3390/molecules26072047. View

11.

Venketaraman V, Lin A, Le A, Kachlany S, Connell N, Kaplan J . Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing. Microb Pathog. 2008; 45(3):173-80. PMC: 2586082. DOI: 10.1016/j.micpath.2008.05.007. View

12.

Kulik E, Thurnheer T, Karygianni L, Walter C, Sculean A, Eick S . Antibiotic Susceptibility Patterns of and Strains from Different Decades. Antibiotics (Basel). 2019; 8(4). PMC: 6963212. DOI: 10.3390/antibiotics8040253. View

13.

Haubek D, Ennibi O, Poulsen K, Benzarti N, Baelum V . The highly leukotoxic JP2 clone of Actinobacillus actinomycetemcomitans and progression of periodontal attachment loss. J Dent Res. 2004; 83(10):767-70. DOI: 10.1177/154405910408301006. View

14.

Wu Y, Song Z, Wang H, Han H . Endogenous stimulus-powered antibiotic release from nanoreactors for a combination therapy of bacterial infections. Nat Commun. 2019; 10(1):4464. PMC: 6775118. DOI: 10.1038/s41467-019-12233-2. View

15.

Lee Y, Thompson D . Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017; 9(5). PMC: 5557698. DOI: 10.1002/wnan.1450. View

16.

Haubek D, Johansson A . Pathogenicity of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans and its geographic dissemination and role in aggressive periodontitis. J Oral Microbiol. 2014; 6. PMC: 4139931. DOI: 10.3402/jom.v6.23980. View

17.

Renvert S, Wikstrom M, Dahlen G, Slots J, Egelberg J . Effect of root debridement on the elimination of Actinobacillus actinomycetemcomitans and Bacteroides gingivalis from periodontal pockets. J Clin Periodontol. 1990; 17(6):345-50. DOI: 10.1111/j.1600-051x.1990.tb00029.x. View

18.

Andremont A, Couvreur P . Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents. 2000; 13(3):155-68. DOI: 10.1016/s0924-8579(99)00121-1. View

19.

Lewis K . The Science of Antibiotic Discovery. Cell. 2020; 181(1):29-45. DOI: 10.1016/j.cell.2020.02.056. View

20.

Haubek D, Poulsen K, Westergaard J, Dahlen G, Kilian M . Highly toxic clone of Actinobacillus actinomycetemcomitans in geographically widespread cases of juvenile periodontitis in adolescents of African origin. J Clin Microbiol. 1996; 34(6):1576-8. PMC: 229068. DOI: 10.1128/jcm.34.6.1576-1578.1996. View